New Drug, Zelboraf, May Benefit Inoperable Melanoma Patients
September 28, 2011
Our increased exposure to high levels of radiation and UV light from the sun makes it no surprise that skin cancer has become a major concern over the last 15 years. Historically, skin cancer’s most severe form, melanoma, has been extremely deadly. However, a new drug on the market that has recently been approved by the Food and Drug Administration (FDA) may help save the lives of those diagnosed inoperable.
WWLTV Eyewitness News reports the drug was able to help a man who was part of the drug trials. The man had melanoma removed in 1998, but eleven years later doctors told him it had traveled to his lungs, and that he had roughly nine months to live. Unfortunately, he was not a candidate for surgery, and was left to sit back and wait.
Then one day, the man got an offer to be a part of a clinical trial on a new treatment program focusing on the drug Zelboraf. After several months, the tumor shrunk to only five percent of its original size and has remained that way.
The Louisiana Drug Injury Attorneys with Dudley Debosier Injury Lawyers agree with doctors and experts that the best way to avoid skin cancer all together is to protect yourself by wearing sunscreen when outdoors, and by always having moles or freckles that exhibit a change in size, color, or shape examined by a medical professional.
Popularity: 2% [?]
Tags: Inoperable melanoma patient, Louisiana Drug Injury Lawyer, Louisiana Medical Malpractice Lawyer, Melanoma treatement, skin cancer treatment, Zelboraf